A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...
RNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing ...
Offering twice-yearly Covid vaccination to adults aged 80 years and older would cost the HSE an additional €112 million over ...
A COVID-19 vaccine study blocked by the CDC's acting director was published in a scientific journal. The study affirmed that ...
A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of ...
Moderna ( MRNA 1.03%) has been on fire this year. As of this writing, the company's shares have slightly more than doubled to ...
A study looking at the effectiveness of the COVID-19 vaccine was published Tuesday after it was blocked from being included ...
A study on COVID-19 vaccine effectiveness has been published after being blocked from a government health journal. The study ...
An inquest is investigating whether the Covid jab was linked to the death of an 85-year-old woman who suffered a stroke days after it was administered. Mohinder Kaur Mahal had a stroke on 26 October ...
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results